Published in BMJ Case Rep on November 21, 2013
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (1994) 39.60
Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med (2005) 7.83
Kaposi's sarcoma. N Engl J Med (2000) 6.81
The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med (1996) 5.56
Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature (1999) 3.93
Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California. MMWR Morb Mortal Wkly Rep (1981) 3.78
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet (1998) 3.77
Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol (2002) 3.20
Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol (1999) 3.19
Kaposi's sarcoma in rheumatic diseases. Semin Arthritis Rheum (2003) 1.93
Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation (2004) 1.68
Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature (2010) 1.57
A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer. Clin Cancer Res (2004) 1.56
Cyclosporin A inhibits the antigen-presenting functions of freshly isolated human Langerhans cells in vitro. J Invest Dermatol (1991) 1.44
The enigmas of Kaposi's sarcoma. Science (1998) 1.39
Management of AIDS-related Kaposi's sarcoma. Lancet Oncol (2007) 1.26
Non-AIDS associated Kaposi's sarcoma: clinical features and treatment outcome. PLoS One (2011) 1.19
Roles of the immune system in skin cancer. Br J Dermatol (2011) 1.12
Identification of human herpesvirus 8-specific cytotoxic T-cell responses. J Virol (1999) 1.07
Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression. Transpl Int (2008) 1.04
Sirolimus conversion for patients with posttransplant Kaposi's sarcoma. Am J Transplant (2006) 1.03
Kaposi's sarcoma in patients with ulcerative colitis receiving immunosuppressive drugs: report of a case. Turk J Gastroenterol (2011) 0.98
Development of multiple malignancies after immunosuppression in a patient with Wegener's granulomatosis. Rheumatol Int (2005) 0.89
Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication. J Virol (2002) 0.88
Telangiectatic Kaposi's sarcoma. Occurrence in a patient with thymoma and myasthenia gravis receiving long-term immunosuppressive therapy. Arch Dermatol (1982) 0.85
Reccurence of Kaposi's sarcoma after increased exposure to sirolimus. Int Immunopharmacol (2006) 0.85
Human herpesvirus 8 serological markers and viral load in patients with AIDS-associated Kaposi's sarcoma in Central African Republic. J Clin Microbiol (2005) 0.85
Cyclosporine preconditions dendritic cells during differentiation and reduces IL-2 and IL-12 production following activation: a potential tolerogenic effect. Transplant Proc (2003) 0.83
Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma. Transplant Proc (2005) 0.82
Kaposi's sarcoma during immunosuppressive therapy for atopic dermatitis. Dermatology (1997) 0.82
Serological and immunohistochemical detection of human herpesvirus 8 in Kaposi's sarcoma after immunosuppressive therapy for bullous pemphigoid. Br J Dermatol (2001) 0.81
Kaposi's sarcoma associated with tumour necrosis factor alpha neutralising therapy. Ann Rheum Dis (2003) 0.81
Cutaneous Kaposi sarcoma which developed in a patient with aplastic anaemia using immunosuppressive therapy--description of the first adult case. Ann Acad Med Singapore (2007) 0.81
Opportunistic infections in the cardiac transplant patient. Curr Opin Cardiol (1996) 0.80
Kaposi's sarcoma (angioreticulomatosis). Postgrad Med (1953) 0.80
A case of Kaposi's sarcoma following treatment of membranoproliferative glomerulonephritis and a review of the literature. Ren Fail (2007) 0.80
Kaposi's sarcoma in an atopic dermatitis patient: a case report and a review of literature. Pediatr Dermatol (2011) 0.80
Inhibited differentiation of Langerhans cells in the rat epidermis upon systemic treatment with cyclosporin A. Histol Histopathol (2001) 0.79
Kaposi sarcoma in a patient with giant cell arteritis. Dermatol Online J (2006) 0.78
Kaposi's sarcoma associated with treatment with adalimumab. Dermatol Ther (2012) 0.77
Kaposi's disease in a patient on adalimumab for rheumatoid arthritis. Joint Bone Spine (2009) 0.76
Selective effects of cyclosporine a on Th2-skewed dendritic cells matured with viral-like stimulus by means of toll-like receptors. Transplantation (2008) 0.76
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet (2006) 9.99
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet (2010) 8.48
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet (2006) 4.55
Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet (2007) 3.94
A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet (2009) 2.96
Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci (2009) 2.71
Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol (2008) 2.67
The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol (2008) 2.53
Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol (2006) 2.22
Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol (2008) 2.16
Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol (2009) 2.03
Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect. J Invest Dermatol (2011) 1.97
Filaggrin in atopic dermatitis. J Allergy Clin Immunol (2008) 1.89
The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol (2013) 1.74
Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol (2007) 1.71
An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis (2010) 1.70
Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J Allergy Clin Immunol (2011) 1.68
Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol (2008) 1.67
Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J Invest Dermatol (2006) 1.62
Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol (2007) 1.57
Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc Natl Acad Sci U S A (2004) 1.56
Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol (2002) 1.42
Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis. Nat Genet (2009) 1.31
Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects. J Allergy Clin Immunol (2013) 1.30
Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Blood (2013) 1.23
Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes. J Allergy Clin Immunol (2010) 1.23
Filaggrin in atopic dermatitis. J Allergy Clin Immunol (2009) 1.22
Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. Blood (2009) 1.21
Copy-number mutations on chromosome 17q24.2-q24.3 in congenital generalized hypertrichosis terminalis with or without gingival hyperplasia. Am J Hum Genet (2009) 1.12
Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol (2010) 1.12
Filaggrin variants confer susceptibility to asthma. J Allergy Clin Immunol (2008) 1.12
Cantú syndrome: report of nine new cases and expansion of the clinical phenotype. Am J Med Genet A (2011) 1.11
High-density genotyping study identifies four new susceptibility loci for atopic dermatitis. Nat Genet (2013) 1.11
Absence of RECQL4 mutations in poikiloderma with neutropenia in Navajo and non-Navajo patients. Am J Med Genet A (2003) 1.10
Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy. J Clin Oncol (2012) 1.09
RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum Mutat (2013) 1.09
Haploinsufficiency for AAGAB causes clinically heterogeneous forms of punctate palmoplantar keratoderma. Nat Genet (2012) 1.08
Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J Allergy Clin Immunol (2012) 1.07
Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease. Hum Mutat (2013) 1.07
Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Am J Clin Pathol (2013) 1.06
A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita. J Dermatol Sci (2007) 1.00
Atopic eczema and the filaggrin story. Semin Cutan Med Surg (2008) 0.97
Chromosome 11q13.5 variant associated with childhood eczema: an effect supplementary to filaggrin mutations. J Allergy Clin Immunol (2010) 0.97
Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk. J Allergy Clin Immunol (2008) 0.96
Response to IL-1-receptor antagonist in a child with familial cold autoinflammatory syndrome. Pediatr Dermatol (2007) 0.96
An unusual N-terminal deletion of the laminin alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndrome. Hum Mol Genet (2003) 0.95
A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum Mol Genet (2013) 0.95
Deletion of Late Cornified Envelope 3B and 3C genes is not associated with atopic dermatitis. J Invest Dermatol (2010) 0.94
Ichthyosis prematurity syndrome: a case report and review of known mutations. Pediatr Dermatol (2014) 0.94
Systemic therapies for severe atopic dermatitis in children and adults. J Allergy Clin Immunol (2013) 0.92
Disorders of keratinisation: from rare to common genetic diseases of skin and other epithelial tissues. Ulster Med J (2007) 0.92
Development of allele-specific therapeutic siRNA in Meesmann epithelial corneal dystrophy. PLoS One (2011) 0.91
Gender- and gestational age-specific body fat percentage at birth. Pediatrics (2011) 0.90
The role of filaggrin loss-of-function mutations in atopic dermatitis. Curr Opin Allergy Clin Immunol (2008) 0.90
Filaggrin gene mutation associations with peanut allergy persist despite variations in peanut allergy diagnostic criteria or asthma status. J Allergy Clin Immunol (2013) 0.87
Colony-stimulating factors for febrile neutropenia. N Engl J Med (2013) 0.87
Identification of a novel C16orf57 mutation in Athabaskan patients with Poikiloderma with Neutropenia. Am J Med Genet A (2010) 0.87
Filaggrin null alleles are not associated with psoriasis. J Invest Dermatol (2007) 0.86
PHACE syndrome: MRI of intracerebral vascular anomalies and clinical findings in a series of 12 patients. Pediatr Radiol (2011) 0.83
Two cases of primarily palmoplantar keratoderma associated with novel mutations in keratin 1. J Invest Dermatol (2002) 0.82
Heritable filaggrin disorders: the paradigm of atopic dermatitis. J Invest Dermatol (2012) 0.82
Newborn transepidermal water loss values: a reference dataset. Pediatr Dermatol (2013) 0.82
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in the Irish population. J Pediatr Endocrinol Metab (2006) 0.81
Explanations for social inequalities in preterm delivery in the prospective Lifeways cohort in the Republic of Ireland. Eur J Public Health (2011) 0.80
Mediastinal and neck kaposiform hemangioendothelioma: report of three cases. Pediatr Dermatol (2009) 0.79
Mutations in the SASPase gene (ASPRV1) are not associated with atopic eczema or clinically dry skin. J Invest Dermatol (2012) 0.79
Old King coal - molecular mechanisms underlying an ancient treatment for atopic eczema. J Clin Invest (2013) 0.78
Thalidomide therapy for the treatment of hypertrophic herpes simplex virus-related genitalis in HIV-infected individuals. Clin Infect Dis (2007) 0.78
Comment on "Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade". J Immunol (2006) 0.77
Childhood eczema and the importance of the physical environment. J Invest Dermatol (2013) 0.76
Second International Conference on a classification of ectodermal dysplasias: development of a multiaxis model. Am J Med Genet A (2014) 0.76
Methylenetetrahydrofolate reductase (MTHFR) deficiency presenting as a rash. Am J Med Genet A (2012) 0.75
Corrigendum: Transcriptional regulator PRDM12 is essential for human pain perception. Nat Genet (2015) 0.75
Carrier status for the common R501X and 2282del4 filaggrin mutations is not associated with hearing phenotypes in 5,377 children from the ALSPAC cohort. PLoS One (2009) 0.75
Successful treatment of florid cutaneous warts with intravenous cidofovir in an 11-year-old girl. Pediatr Dermatol (2008) 0.75
Skin involvement in Down syndrome transient abnormal myelopoiesis. Br J Haematol (2012) 0.75
Gallstone ileus in evolution. ANZ J Surg (2011) 0.75
Use of systemic corticosteroids in management of a large congenital haemangioma of the scalp. Pediatr Dermatol (2012) 0.75
Body Composition within the First 3 Months: Optimized Correction for Length and Correlation with BMI at 2 Years. Horm Res Paediatr (2016) 0.75